May 21, 2014
New Collaboration Aims to Develop Disease-Specific Experimental Models for Translational Medical Research
May 21, 2014
Santa Clara, CA (May 21, 2014) – Crown Bioscience, Inc., a leading global drug discovery and development service company, today announces that it has entered into a strategic partnership with Shin Nippon Biomedical Laboratories, Ltd., a Japan-based...
May 21, 2014
Investment to Fund Rapid Expansion in Translational Platform Technologies for Oncology and Metabolic Diseases
May 19, 2014
SelectScience has been awarded the UK Life Science Employer of the Year Award 2014, as part of the UK Life Science Skills Award Scheme.
May 06, 2014
South Wales, UK, May, 2014.Haydale, the developer of a unique plasma functionalisation process to commercialise graphene, has announced that the National Physical Laboratory (NPL) has characterised and positively reported on graphene nanomaterials..
Apr 23, 2014
Size of collection allows for more informed preclinical decision making on prospective drug candidates
Apr 22, 2014
Meaningful “quick read” whitepaper “Life Science Trends 2014” also offers exclusive feature article on Big Data in the Life Sciences
Mar 28, 2014
Santa Clara, CA (February 10 2014) – Crown Bioscience, Inc., a leading global drug discovery and development service company, will be highlighting its expertise in Oncology Drug Discovery on booth #2111 at the AACR (American Association of Cancer...
Mar 19, 2014
South Wales, UK (19th March 2014) - Haydale has announced plans to raise up to £10 million ($16.6 million) via an IPO on the UK's AIM.
Mar 18, 2014
(18th March 2014) - SmartKem Ltd., leading developer of high performance, organic semiconductor materials for flexible displays & electronics, is delighted to announce that a recent Knowledge Transfer Partnership (KTP) with Bangor University, UK, has.